These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19911018)

  • 21. Adult-onset vitelliform detachment unresponsive to monthly intravitreal ranibizumab.
    Kandula S; Zweifel S; Freund KB
    Ophthalmic Surg Lasers Imaging; 2010; 41 Suppl():S81-4. PubMed ID: 21117608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular amd.
    Keane PA; Chang KT; Liakopoulos S; Jivrajka RV; Walsh AC; Sadda SR
    Retina; 2009 May; 29(5):592-600. PubMed ID: 19289984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between retinal thickness and retinal pigment epithelium elevation in age-related macular degeneration.
    Blair MP; Gupta M; Blair NP; Shahidi M
    Ophthalmic Surg Lasers Imaging; 2010; 41(2):175-81. PubMed ID: 20307034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration.
    Framme C; Wolf S; Wolf-Schnurrbusch U
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5965-9. PubMed ID: 20574019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration.
    McKibbin M; Papastefanou V; Matthews B; Cook H; Downey L
    Eye (Lond); 2010 Jun; 24(6):994-8. PubMed ID: 19911016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
    Spaide RF; Chang LK; Klancnik JM; Yannuzzi LA; Sorenson J; Slakter JS; Freund KB; Klein R
    Am J Ophthalmol; 2009 Feb; 147(2):298-306. PubMed ID: 18929354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal pigment epithelial tear after intravitreal ranibizumab.
    Bakri SJ; Kitzmann AS
    Am J Ophthalmol; 2007 Mar; 143(3):505-7. PubMed ID: 17317396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential hyperacuity perimeter in assessing responsiveness to ranibizumab therapy for exudative age-related macular degeneration.
    Querques G; Berboucha E; Leveziel N; Pece A; Souied EH
    Br J Ophthalmol; 2011 Jul; 95(7):986-91. PubMed ID: 21183512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcomes of conventional or high-dose ranibizumab for vascularized pigment epithelial detachment based on lesion subtypes.
    Chan CK; Sarraf D; Abraham P
    Eur J Ophthalmol; 2018 Nov; 28(6):677-683. PubMed ID: 29575941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting.
    Querques G; Azrya S; Martinelli D; Berboucha E; Feldman A; Pece A; Coscas G; Soubrane G; Souied EH
    Br J Ophthalmol; 2010 Mar; 94(3):292-6. PubMed ID: 19951942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration.
    Spaide RF
    Am J Ophthalmol; 2009 Apr; 147(4):644-52. PubMed ID: 19152869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials.
    Rosenfeld PJ; Shapiro H; Tuomi L; Webster M; Elledge J; Blodi B;
    Ophthalmology; 2011 Mar; 118(3):523-30. PubMed ID: 20920825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early clinical experience with ranibizumab for occult and minimally classic neovascular membranes in age-related macular degeneration.
    Mantel I; Zografos L; Ambresin A
    Ophthalmologica; 2008; 222(5):321-3. PubMed ID: 18617755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab.
    Sayanagi K; Sharma S; Yamamoto T; Kaiser PK
    Ophthalmology; 2009 May; 116(5):947-55. PubMed ID: 19232732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration.
    Boyer DS; Heier JS; Brown DM; Francom SF; Ianchulev T; Rubio RG
    Ophthalmology; 2009 Sep; 116(9):1731-9. PubMed ID: 19643495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal pigment epithelium tears following intravitreal ranibizumab therapy.
    Kiss C; Michels S; Prager F; Geitzenauer W; Schmidt-Erfurth U
    Acta Ophthalmol Scand; 2007 Dec; 85(8):902-3. PubMed ID: 17408387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results.
    Parravano M; Oddone F; Tedeschi M; Chiaravalloti A; Perillo L; Boccassini B; Varano M
    Retina; 2010; 30(7):1017-24. PubMed ID: 20224469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
    Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.